Cleerly LABS vs Libby Echo:Prio

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cleerly
VS
by Dyad Medical

AI Verdict

Cleerly LABS and Libby Echo:Prio are both FDA-cleared AI tools for cardiac imaging analysis, but they serve distinct clinical purposes. Cleerly LABS specializes in analyzing coronary CT angiography (CCTA) to assess coronary artery disease, plaque, and stenosis. In contrast, Libby Echo:Prio focuses on echocardiogram analysis to provide automated measurements and decision support for cardiac function quantification.

Choose Cleerly LABS if…

Choose Cleerly LABS if your primary need is a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) to precisely detect, quantify, and characterize atherosclerosis and stenosis. This tool is ideal for clinicians focused on personalized heart disease management, including tracking disease progression over time and detailed plaque assessment.

View Cleerly LABS →

Choose Libby Echo:Prio if…

Choose Libby Echo:Prio if you require fast, consistent, and automated cardiac measurements from echocardiograms to support clinical decision-making. This cloud-based platform is best suited for scenarios where remote access, high-volume analysis, and standardized quantification of cardiac function are critical.

View Libby Echo:Prio →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly LABS Libby Echo:Prio
Pricing Per analysis Custom
Deployment Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. Cloud-based
BAA Available Yes AI-estimated No AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated No AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cleerly LABS

Cleerly LABS is a web-based software with features like 3D visualization of coronary arteries and integration with PACS, RIS, and EHR via Cleerly Proxy. While Libby Echo:Prio is also cloud-based and integrates into workflows, Cleerly's emphasis on comprehensive 3D visualization for complex CCTA data offers a potentially richer and more intuitive user experience for detailed cardiac imaging analysis.

Clinical Value

Cleerly LABS

Cleerly LABS offers comprehensive analysis of CCTA to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management and tracking disease progression over time. Libby Echo:Prio provides fast, data-driven echocardiogram analysis for automated cardiac measurements and decision support. While both are FDA-cleared and valuable, Tool A's broader scope in characterizing plaque and tracking disease progression for heart attack prevention presents a more comprehensive and proactive clinical impact.

Pricing & Value

Cleerly LABS

Cleerly LABS provides transparent pricing details, including a retail price and a discounted offer, along with information on potential insurance coverage and out-of-pocket costs. In contrast, Libby Echo:Prio's pricing is listed as 'custom' with a directive to 'contact vendor for details'. This lack of transparency for Tool B makes it impossible to assess its value proposition without direct engagement, giving Tool A a clear advantage in pricing clarity.

Enterprise Readiness

Cleerly LABS

Cleerly LABS explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) in place, along with cloud-based deployment on AWS and integration capabilities with PACS, RIS, and EHR. Libby Echo:Prio, while FDA-cleared and cloud-based, explicitly states 'no' for both BAA and HIPAA compliance. This critical difference makes Tool A significantly more prepared for enterprise adoption in healthcare settings.

Innovation

Cleerly LABS

Cleerly LABS aims to 'create a new standard of care to eliminate heart attacks' through AI-powered CCTA for comprehensive plaque assessment and tracking disease progression. Libby Echo:Prio focuses on fast, data-driven echocardiogram analysis for automated measurements and decision support. While both utilize AI for cardiac imaging, Tool A's ambition to redefine preventative care through detailed plaque characterization and longitudinal tracking demonstrates a higher degree of innovation.

Support & Docs

Cleerly LABS

Cleerly LABS provides clear channels for client support, including a dedicated form for technical support and specified operating hours (Monday-Friday, 10 am ET to 6 pm ET). It also offers resources like billing guidelines and integration support from a 'Solution Architect team'. Dyad Medical's website for Libby Echo:Prio offers a general contact form and email for inquiries, but lacks specific details on dedicated technical support, user documentation, or a knowledge base for its medical AI product.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly LABS Libby Echo:Prio
Name Cleerly LABS Libby Echo:Prio
Company Cleerly Dyad Medical
Description AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. FDA-cleared, cloud-based AI platform for fast, data-driven echocardiogram analysis, providing decision support and automated cardiac measurements for clinicians.
Primary Imaging Modality Coronary CT Angiography (CCTA) Echocardiogram
Key Features (Selected) AI-powered CCTA image analysis, Comprehensive coronary plaque assessment (volume, type), Stenosis detection and quantification, Ischemia detection (with Cleerly ISCHEMIA module) AI-powered cardiac image analysis, Fast, data-driven echocardiogram image analysis, Decision-making support for cardiac function quantification, Automated estimation of cardiac measurements

Videos

Demos, reviews, and walkthroughs featuring Cleerly LABS and Libby Echo:Prio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly LABS is designed for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. Libby Echo:Prio, on the other hand, provides fast, data-driven analysis of echocardiograms, offering decision support and automated cardiac measurements for clinicians.
Cleerly LABS is HIPAA compliant and offers a Business Associate Agreement (BAA). In contrast, Libby Echo:Prio is explicitly stated as not HIPAA compliant and does not have a BAA available.
Cleerly LABS provides comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with its ISCHEMIA module), 3D visualization of coronary arteries, and personalized heart disease risk assessment. Libby Echo:Prio offers automated estimation of cardiac measurements, decision-making support for cardiac function quantification, and provides an immediately-available second opinion with consistent analysis and low inter/intra-analyst variability.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.